← Back
$VRTX All transactions

VERTEX PHARMACEUTICALS INC / MA

D

$ Value

Shares

1,001

Price

Filed

May 5

Insider

Name

Upadhyay Suketu

Title

CIK

0001533149

Roles

Director

Transaction Details

Transaction Date

2025-05-01

Code

D

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,354

Footnotes

Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. | Upon the vesting of restricted stock units granted to Mr. Upadhyay on May 1, 2024, Mr. Upadhyay deferred the receipt of 1,001 shares of common stock and received instead 1,001 deferred stock units pursuant to our deferred compensation plan. As a result, Mr. Upadhyay is reporting the disposition of 1,001 shares of common stock in exchange for an equal number of deferred stock units. | Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Upadhyay's service on our board of directors, (ii) a change of control of our company and (iii) Mr. Upadhyay's disability or death.

Filing Info

Accession No.

0000875320-25-000190

Form Type

4

Issuer CIK

0000875320

Upadhyay Suketu's History

Date Ticker Type Value
2026-04-15 VRTX A $36K
2026-01-15 VRTX A $36K
2025-11-10 ZBH M $0
2025-11-10 ZBH F $415K
2025-11-10 ZBH M $0
2025-10-24 ZBH A $0
2025-10-15 VRTX A $36K
2025-07-15 VRTX A $36K
2025-05-01 VRTX A $0
2025-05-01 VRTX D

Other Insiders at VRTX (90d)

Insider Bought Sold Last
SACHS BRUCE I 2026-04-15
WAGNER CHARLES F JR
EVP, CO & FO
2026-01-22
LEIDEN JEFFREY M
Executive Chairman
2026-01-22
Garber Alan M 2026-04-15
Sachdev Amit
EVP Chief Patient & Ext Af Off
2026-01-22
Upadhyay Suketu 2026-04-15
ALTSHULER DAVID
EVP, Chief Scientific Officer
2026-01-22
Kewalramani Reshma
CEO & President
2026-01-22
Biller Jonathan
EVP and Chief Legal Officer
$886K 2026-02-11
Tatsis Ourania
EVP, Chief Reg. & Quality Off.
2026-01-22
Bozic Carmen
EVP and CMO
$1.1M 2026-03-27
Liu Joy
EVP and Chief Legal Officer
$439K 2026-04-01
Ambrose Kristen
SVP & Chief Accounting Officer
$634K 2026-02-11
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
$806K 2026-02-11
McKechnie Duncan
EVP, Chief Commercial Officer
2026-01-22
Bunnage Mark E.
EVP, Chief Scientific Officer
$931K 2026-02-11